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SUMMARY
The human pathogenic bacterium Pseudomonas
aeruginosa produces a fucose-specific lectin, LecB,
implicated in tissue attachment and the formation of
biofilms. To investigate if LecB inhibition disrupts
these processes, high-affinity ligands were obtained
by screening two 15,536-member combinatorial
libraries of multivalent fucosyl-peptide dendrimers.
The most potent LecB-ligands identified were
dendrimers FD2 (C-Fuc-LysProLeu)4(LysPheLysIle)2
LysHisIleNH2 (IC50 = 0.14 mM by ELLA) and
PA8 (OFuc-LysAlaAsp)4(LysSerGlyAla)2 LysHisIleNH2
(IC50 = 0.11 mM by ELLA). Dendrimer FD2 led to com-
plete inhibition ofP.aeruginosabiofilm formation (IC50
 10 mM) and induced complete dispersion of estab-
lished biofilms in the wild-type strain and in several
clinical P. aeruginosa isolates. These experiments
suggest that LecB inhibition by high-affinity multiva-
lent ligands could represent a therapeutic approach
against P. aeruginosa infections by inhibition of bio-
film formation and dispersion of established biofilms.
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic human pathogen
causing a variety of infections and is regarded as a primary cause
of death in immunocompromised patients and those with cystic
fibrosis or cancer. There is an urgent need to develop novel
therapeutic agents effective against P. aeruginosa because this
bacterium exhibits multiantibiotic resistance. This resistance is
mediated in part by the formation of surface attached biofilms,
which form a physical barrier to antibiotic penetration and pro-
vide an altered microenvironment (Wagner and Iglewski, 2008).
Targeting the mechanisms of tissue adhesion and biofilm devel-
opment should increase antimicrobial tolerance and facilitate
clearance by the host immune system (Drenkard, 2003), in par-
ticular by targeting key mediators such as the galactose-specific
lectin LecA (PA-IL) and the fucose-specific lectin LecB (PA-IIL)
(Loris et al., 2003; Mitchell et al., 2002; Tielker et al., 2005; Diggle
et al., 2006).
One might expect that multivalent ligands against the galacto-
side or fucoside-binding lectins, LecA and LecB, respectively,
might exert useful biofilm blocking activities. Indeed mutants
lacking either of these lectins are impaired in biofilm formation
(Mewe et al., 2005; Tielker et al., 2005), whereas isopropyl-
b-thiogalactoside (IPTG) promotes LecA-dependent biofilm
dispersal (Mewe et al., 2005). LecA and LecB cause inhibition
of human airway cilia beating, which could be abolished by
preincubation with galactose and fucose (Mewe et al., 2005).
Furthermore, an induced otitis externa diffusa (Steuer et al.,
1993) and respiratory tract infections (von Bismarck et al.,
2001) due to P. aeruginosa have been successfully treated by
concentrated solutions of these carbohydrates. Nevertheless,
these effects were observed using high concentrations of rela-
tively weak lectin ligands, and the link between the antibacterial
effects and lectin binding was not formally established. To test if
a therapeutic strategy against P. aeruginosa would indeed be
possible based on lectin inhibitors, it would be necessary to
identify high-affinity ligands to investigate whether such ligands
can perturb biofilm processes in the live bacterium.
Lectins such as LecA and LecB are ubiquitous carbohydrate-
binding proteins that occur in all known life forms. These proteins
bind tomultivalent carbohydrates on cell surfaces such as glyco-
proteins and glycolipids, and mediate a broad range of cellular
and tissue adhesion processes. The carbohydrate-binding sites
of these lectins are generally specific but rather weak, yet effi-
cient ligand recognition is achieved by a multivalency effect
upon binding, called the cluster effect (Lee and Lee, 1995; Lund-
quist and Toone, 2002). It has been shown in a number of sys-
tems that this multivalency effect can be exploited to obtain
high-affinity synthetic ligands against various types of lectins in
the form of glycoclusters (Kiessling et al., 2006), glycopolymers
(Mammen et al., 1998), and glycodendrimers (Newkome et al.,
2001; Tomalia and Dvornic, 2002; Lee et al., 2005; Roy, 2003;
Deguise et al., 2007). Octavalent dendrimers with galabioseChemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1249
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bacterium Streptococcus suis, revealing the potential of glyco-
dendrimers as anti-adhesins (Joosten et al., 2004). These prece-
dent results suggested that multivalent fucose ligands should be
a suitable compound class to inhibit P. aeruginosa lectins.
We focused our search for high-affinity multivalent ligands to-
ward LecB because fucose bindsmore strongly to LecB than ga-
lactose to LecA (Imberty et al., 2004), implying that high-affinity
ligands might be more easily identified for LecB. Thus, we hy-
pothesized that useful ligands tailored to these lectins might be
accessible based on our recently reported combinatorial synthe-
sis of multivalent peptide dendrimers (Clouet et al., 2004), which
follows the principle of split-and-mix synthesis (Furka et al.,
1991) and was originally developed in the context of enzyme
model studies (Darbre and Reymond, 2006). These compounds
belong to the general class of amide-bond-containing den-
drimers (Crespo et al., 2005), and the related lysine-branched
multivalent peptides have been previously used in various bio-
medical applications such as synthetic vaccines (Sadler and
Tam, 2002). Glycodendrimers assembled on a peptide back-
bone are more easily accessible than other synthetic dendrimers
because they are prepared from standard amino acid building
blocks by the same solid-phase synthesis methods used for lin-
ear peptides. Peptide dendrimers can furthermore be tuned by
variation of amino acid side chains for specific affinity toward
the target mediated via secondary interactions outside the
carbohydrate binding site, as well as for other properties such
as solubility. Preliminary studies in the context of drug delivery
had shown that glycosylated peptide dendrimers are not intrinsi-
cally cytotoxic (Lagnoux et al., 2005).
RESULTS
Identification of High-Affinity Ligands toward LecB
Two 15,625-member combinatorial libraries of peptide den-
drimers were prepared and functionalized with a-L-fucoside
end groups as primary recognition elements for LecB on non-
cleavable Tentagel beads as the solid support. Various cationic,
anionic, polar, hydrophobic, or aromatic residues were placed at
the variable positions X1–X6 to provide a diverse set of den-
drimers, in an arrangement allowing bead decoding by amino
acid analysis as described previously (Clouet et al., 2004). The
terminal amino groups were acylated either with the protected
a-C-fucoside 1 or with the protected a-carboxyphenyl fucoside
2, followed by acidic removal of the side-chain-protecting
groups and deacetylation, to provide solid-supported fucosy-
lated dendrimer libraries L1 and L2, respectively (Figure 1).
Preliminary screening of library L1 in an enzyme-coupled
on-bead binding assay with a biotinylated fucose-specific lectin
from the plant Ulex europaeus showed mostly cationic amino
acids in the dendrimer sequences of stained beads (e.g., FD1–
FD4, Table 1),(Kolomiets et al., 2007), an effect also seen in diva-
lent glycopeptide dendrimers (Johansson et al., 2007). Screen-
ing of L1 and L2 with rhodamine-B labeled LecB similarly gave
sequences containing cationic residues, although neutral and
anionic amino acids were also present (e.g., PA5–PA9, Table
1). The selected hits were resynthesized by solid phase peptide
synthesis (SPPS), cleaved from the resin, and purified as soluble
dendrimers. When tested in an enzyme-linked lectin assay
(ELLA), the dendrimers inhibited LecB with IC50 in the range of
0.11 to 0.75 mM, with up to a 100-fold affinity enhancement rel-
ative to fucose (Table 1; see Figure S1 available online).
The diversity of amino acid sequences compatible with good
binding to LecB suggested that the affinity enhancement was
primarily due tomultivalency (Kitov and Bundle, 2003). Themulti-
valency effect on binding was further evidenced in the case of
FD2 by investigating lower-valency analogs. Thus, tripeptide
2G0 featuring the terminal branch of FD2 exhibited an affinity
similar to that of the referencemonovalent ligand a-NPF (p-nitro-
phenyl-a-L-fucoside). Similarly, the first-generation dendrimer
2G1 featuring the first- and second-generation branches with
two fucoses exhibited the same relative potency per fucose as
the monovalent ligands.
Inhibition and Dispersion of P. aeruginosa Biofilms
Dendrimers, FD2, PA5, PA6, PA8, and PA9 were selected for
a study of P. aeruginosa biofilm inhibition. Biofilm inhibition
was investigated using the steel coupon assay in which the for-
mation of biofilms in culture suspensions is revealed by staining
cells attached to the steel surface (Figure S2) (Diggle et al., 2006).
Addition of a-NPF as reference LecB ligand or IPTG as reference
LecA ligand to the cultures reduced biofilm formation by 30%
Figure 1. Synthesis and Structure of the C-Fucosyl Peptide Den-
drimer Libraries, Displayed on Tentagel Resin as Solid Support
The ‘‘link’’ between amino acid X6 and the fucose is either an acetyl spacer in
the C-fucosyl library L1 or phenoxyacyl in the O-fucoside library L2, obtained
by coupling the corresponding building blocks 1 and 2. The positions X1–X6
display various amino acids according to the table at right (one-letter codes
of L-amino acids) as a ‘‘one-bead-one-compound’’ library obtained by the
split-and-mix SPPS protocol.1250 Chemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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neously. Although the effect of monovalent control ligands was
only weak, addition of the dendrimers to the culture caused
a strong reduction of biofilm formation in the assay (Figure 2,
black bars, and Figure S2). The most potent inhibition was
observed with ligand FD2, which showed a complete inhibition
of biofilm formation at 50 mM (see below). A 55% inhibition was
observed with FD2 at 10 mM, and the effect was increased to
70% in the presence of IPTG (Figure S3). The dendrimers were
also remarkably active when tested in a biofilm dispersion assay,
which revealed the ability of the ligand to disrupt already estab-
lished biofilms, a closer resemblance to chronic infections (Fig-
ure 2, gray bars, and Figure S5). In both biofilm inhibition and dis-
persion assays, the effect observed with the dendrimers was
much stronger than the partial effect observed with the monova-
lent a-NPF. Quite importantly, bacterial growth was not affected
by any of the ligands, indicating that the observed effect was not
due to the toxicity of the dendrimers (Figure S4b).
The best biofilm formation inhibitor FD2was also the most po-
tent in the dispersion assay and in fact caused complete clear-
ance of P. aeruginosa colonies from the steel coupons. Analysis
of the steel coupons after biofilm dispersal using confocal imag-
ing clearly indicated that any residual staining after treatment
with FD2 was not caused by attached P. aeruginosa cells but
probably by residues from formerly attached P. aeruginosa cells
or by impurities (Figure 3). Most interestingly, FD2 also inhibited
biofilm formation by several P. aeruginosa clinical isolates de-
rived from the cystic fibrosis lung, suggesting that the inhibitory
effect is general and supporting the potential of these den-
drimers in a clinical context (Figure 4).
LecB Ligands Do Not Block Biofilms in DlecB Strains
Evidence that biofilm inhibition was mediated by LecB-binding
was provided by investigating biofilm inhibition in deletion mu-
tants lacking either the lecA (PAO1DlecA) or lecB (PAO1DlecB)
genes. The chromosomal lecA and lecB mutants were con-
structed by standard in-frame deletion and exhibited normal
growth. The monovalent control ligand a-NPF inhibited biofilm
formation in wild-type P. aeruginosa PAO1 and in PAO1DlecA
(p = 0.0001 and p = 0.0011, respectively) but showed no
reduction in biofilm formation for PAO1DlecB. However, the
galactose ligand, IPTG, inhibited P. aeruginosa PAO1 wild-type
(p < 0.0001) and PAO1DlecB biofilms (p < 0.0001), but not those
of PAO1DlecA (p = 0.20) (Figure 5). Similar to a-NPF, dendrimer
FD2 had no effect on PAO1DlecB biofilm formation (Figure 4).
Together with the fact that the dendrimers are not directly toxic
Table 1. Structure and ELLA Data with P. aeruginosa LecB for Reference Ligands and Glycopeptide Dendrimers from Library L1 or L2
Identified by On-Bead Affinity Assay
Number na Structureb Yieldc (% mg) IC50 (mM) ELLA
d Rel. Pot.e Tot. /Fucose
L-Fuc 1 a-L-Fucose — — 11 ± 1.5 1.0 1.0
a-NPF 1 4-Nitrophenyl-a-L-fucoside — — 5.27 ± 0.55 2.1 2.1
2G0 1 cFuc-LysProLeuNH2 68 140 5.94 ± 1.24 1.9 1.9
2G1 2 (cFuc-LysProLeu)2LysPheLysIleNH2 33 82.3 2.7 ± 0.56 4.1 2.0
FD1 4 (cFuc-LysHisVal)4(LysHisGlyAla)2LysHisIleNH2 6.7 18 0.43 ± 0.11 25.6 6.4
FD2 4 (cFuc-LysProLeu)4(LysPheLysIle)2 LysHisIleNH2 14 38.5 0.14 ± 0.035 78.6 19.7
FD3 4 (cFuc-LysHisLeu)4(LysGluLysIle)2 LysHisIleNH2 4.4 12.4 0.19 ± 0.05 57.9 14.5
FD4 4 (cFuc-LysArgAsp)4(LysSerArgAla)2LysHisIleNH2 4.7 13.2 0.54 ± 0.14 20.4 5.1
PA5 4 (cFuc-GlyArgVal)4(LysGluGlyLeu)2 LysHisIleNH2 10 26 0.75 ± 0.08 14.7 3.7
PA6 4 (cFuc-GlyThrVal)4(LysHisProThr)2LysHisIleNH2 9 22 0.30 ± 0.09 36.7 9.2
PA7 4 (cFuc-GluHisTyr)4(LysTyrGlyAsp)2 LysHisIleNH2 6 22 0.28 ± 0.02 39.3 9.8
PA8 4 (OFuc-LysAlaAsp)4(LysSerGlyAla)2 LysHisIleNH2 12 21 0.11 ± 0.01 100 25
PA9 4 (OFuc-GluHisAsp)4(LysGluValAla)2 LysHisIleNH2 9 17 0.35 ± 0.12 31.4 7.8
aNumber of fucosyl groups in the ligand.
b Linear peptide notation from N to C terminus using three-letter codes for amino acids. Lys denotes a branching lysine with both amino groups
acylated; cFuc, c-fucoside from building block 1; OFuc, O-fucoside from building block 2.
c Yield after purification by preparative HPLC.
dAverage of three independent IC50 determinations with standard deviation.
e Rel. Pot., relative potency = IC50(fucose)/IC50(ligand); rel. pot. per fucose, rel. pot. / n.
Figure 2. Biofilm Assays with P. aeruginosa and Dendrimers
Biofilm inhibition and dispersion were tested with a-NPF (0.5 mM), dendrimers
(0.05mM), andwild-type strain PAO1 (Figure S3). The values are normalized so
that growth without any inhibitor is set to 1. A background control (no bacteria)
gave reading values similar to the ones shown in the graph for FD2 biofilm
assay (0.05 mM). Mean values of three independent readings ± standard
deviation are plotted.Chemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1251
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in suspension cultures in the presence of the ligands (Figure S4b),
these experiments support the hypothesis that the effect of
FD2 on biofilm formation is mediated by specific binding to
LecB.
Crystal Structure of the LecB-2G0 Complex
The dependence of LecB inhibition potency by the glycopeptide
dendrimers on their amino acid composition suggests that part
of their affinity toward LecBmight be caused by secondary inter-
actions with the lectin outside the fucose binding site. A crystal-
lographic study was undertaken to determine the nature of the
glycopeptide dendrimer-lectin interactions.
Crystallization attempts with LecB and FD2 or 2G1 at various
stoichiometries formed precipitates, and no crystals of these
Figure 3. Representative Fluorescent and
Confocal Laser Scanning Micrographic
Images of Acridine-Orange-Stained Bio-
films before and after Dispersion by
Dendrimer FD2
Figure 4. Biofilm Inhibition with a-NPF (0.5 mM) and FD2 (0.05 mM)
of Wild-Type PAO1, DlecB Mutant (PAO1 DlecB), and Three Clinical
Strains (A014, A021, A035)
The values are normalized so that growth of PAO1 without any inhibitor is
set to 1. Mean values of three independent readings ± standard deviation
are plotted.
Figure 5. Biofilm Inhibition with Deletion Mutants Showing the
Effect of IPTG (0.2 mM) and a-NPF(0.5 mM)
The values are normalized so that growth of PAO1 without any inhibitor is set
to 1. Mean values of three independent readings ± standard deviation are
plotted.
complexes could be obtained. However,
a crystal structure of a 1:4 complex of
LecB with tripeptide 2G0 featuring the
terminal arm of FD2 could be obtained.
In this complex, the fucose residues in
each of the four fucose binding sites
are anchored to the binding site via
two Ca2+ ions also coordinated by acidic
side chains from the local chain (Glu95,
Asp96, Asp99, Asp101, and Asp104),
and by the C-terminal carboxyl group
of the adjacent chain (Gly114). This
binding mode is identical to that re-
ported for free fucose in LecB (Imberty
et al., 2004). Furthermore, the tripeptide
arms protrude in solution with only few contacts with the pro-
tein and only partially observable electron density. For the
best-resolved ligand, the conformation of the tripeptide linker
(Lys-Pro-Leu) is well-defined by the experimentally observed
electron density, except for the flexible side chain of the lysine
residue (Figure 6A). The side chain of Asn70 makes an ex-
tended contact with the tripeptide linker, and might help to sta-
bilize this particular conformation. The occurrence of different
ligand conformations in each of the binding sites is most likely
due to local differences in the crystal packing environment,
which select different conformations from the intrinsic variability
in the peptide moiety (Figure 6B). These various poses indicate
that the tripeptide ligand G0 is conformationally labile in its
bound state, in agreement with the relatively low affinity of
2G0 to LecB.1252 Chemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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The multivalency effects observed upon FD2 binding to LecB,
evidenced by the lower affinity of the monovalent and divalent
analogs 2G0 and 2G1, respectively (Table 1), might be caused
by simultaneous coordination of FD2 with two fucose binding
sites, or by lectin-dendrimer interactions involving dendritic
arms not directly involved in presenting the fucose residue occu-
pying the fucose binding site. To investigate this point, a molec-
ular model of the LecB-FD2 complex was constructed. First the
FD2 ligand was assembled, energy minimized, and subjected to
a molecular dynamics simulation over 10 ns in implicit solvent.
The resulting model of the FD2 dendrimer was then combined
Figure 6. Structural Model of the LecB-FD2
Complex
(A) Crystal structure of the LecB-2G0 complex,
detailed view of a single LecB binding site (green)
with the bound 2G0 ligand (yellow). The experi-
mentally observed electron density is shown
as a blue mesh, contoured at a density level of 1
sigma.
(B) Superposition of two distinct conformations
of the 2G0 ligand, observed in LecB subunits A
and B in the crystal structure. The fucose and
lysine residues are in identical positions, but the
proline and leucine residues adopt clearly distinct
conformations.
(C) Model of the dendrimer FD2-LecB complex
obtained by molecular dynamics and energy min-
imization. The Ca2+ ions are shown in magenta
and indicate the location of the fucose binding
pocket. Three binding sites are shown with the
resolved fucosyl residues of 2G0 and the fourth
site is modeled with dendrimer FD2.
with LecB by removing one of the termi-
nal tripeptide arms and fusing it with
that observed in the crystal structure.
The resulting model of the FD2-LecB
complex was then energy-minimized
and subjected to molecular dynamics
simulation using implicit solvent over
100 ps (see supporting information for
details).
The FD2-LecB model thus obtained
showed that the dendrimer molecule is
too small to bridge two distinct fucose
binding sites within the same lectin tetra-
mer (Figure 6C). However, the simulation
suggests that additional protein-den-
drimer contacts outside of the fucose
binding site are possible using the fuco-
syl-tripeptide arm adjacent to the one di-
rectly bound to the fucose binding site.
These additional contacts are predicted
to involve a hydrogen bond between
Arg13 on LecB and the proline carbonyl
group of this dendritic arm as well as
several hydrophobic interactions. Such
interactions could explain the observed
sequence dependence of LecB affinity in the different den-
drimers investigated.
DISCUSSION
The fucose-specific lectin LecB from P. aeruginosa has been
previously shown to be implicated in biofilm formation, although
its exact mechanism of action remains poorly understood. In the
present study, we asked whether specific LecB ligandsmight ef-
ficiently interfere with biofilm formation. To this end, we have
used multivalent fucosyl-peptide dendrimers as ligands, and
the results of our experiments clearly suggest that they indeedChemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1253
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biofilms. The absence of biofilm inhibition by the most potent
ligand FD2 in the lecB deletion strain provides strong evidence
that biofilm inhibition is mediated by direct interaction with
LecB. Biofilm inhibition was observed not only in the laboratory
wild-type P. aeruginosa strain, but also in various clinical
isolates derived from the cystic fibrosis lung, which is an en-
couraging finding in the perspective of therapeutic applications
of dendrimers.
The choice of carbohydrate multivalency as a strategy toward
high-affinity lectin ligands is well reported in the literature for
other lectins, as discussed in the introduction. The crystal struc-
ture of LecB furthermore showed that productive binding inter-
actions with the lectin outside of the fucose binding pocket might
be difficult to achieve due to the absence of other binding
pockets on the protein. Interestingly, the reference ligand
a-NPF bearing a hydrophobic phenyl fucoside group next to
the carbohydrate shows only marginal enhancement of affinity
to the lectin. A survey of several related monovalent aryl fuco-
sides failed to uncover significant affinity gains to LecB (data
not shown). This is in contrast to other lectins such as concanav-
alin A, for which the attachment of an aryl group next to the car-
bohydrate provides quite strong affinity gains (Kanellopoulos
et al., 1996; Loganathan et al., 1992). Although such effects
provided the motivation to investigate library L2 displaying
phenyl fucosides as recognition group, the resulting dendrimers
exhibit similar potency toward LecB compared with the simple
C-fucosyl ligands from library L1.
Our multivalent fucosyl dendrimers exhibit an up to 100-fold
higher affinity toward LecB compared with fucose as estimated
by ELLA. The affinity increase of FD2 over fucose is 46-fold
when estimated by isothermal titration calorimetry (data not
shown). Thus, these glycopeptide dendrimers represent the
strongest multivalent LecB ligands identified to date. Our struc-
tural investigations and the dependence of affinity on the amino
acid sequence of the dendrimers suggest that auxiliary den-
drimer-LecB interactions outside of the fucose binding pocket
are likely to occur. Furthermore, molecular modeling clearly
excludes the possibility of multivalent coordination of a LecB
dimer or tetramer by the same dendrimer. We believe that
the dendrimer leads to the formation of multiprotein aggregates
that effectively remove the soluble LecB from the system. The
formation of such aggregates was clearly indicated by precipi-
tates observed upon attempted crystallization of FD2-LecB
complexes.
The IC50 of the strongest ligand FD2 is approximately 10 mM
for biofilm inhibition, which represents a 50-fold affinity gain
over the monovalent ligand a-NPF. Although the potency gain
is significant, further improvements will be necessary. In the
course of our investigations, synthetic di- and trisaccharide ana-
logs of the natural LecB ligand Lea were reported to bind LecB
approximately 3- to 10-fold stronger than fucose due to addi-
tional contacts outside the fucose binding pocket (Marotte
et al., 2007a), although there was no multivalency effect when
these ligands were displayed as dendrimers (Marotte et al.,
2007b). Synthetic fucosylated polymers were also recently
shown to bind LecB (Morvan et al., 2007). Although none of these
ligands were investigated for their biofilm inhibition potential,
these reports provide clear indications that improvements in
binding should be possible by ligand tuning, as also suggested
by the modulation of affinities resulting from variations in amino
acids in the dendrimers.
The investigated peptide dendrimers did not show any detect-
able toxicity to the bacterium aside from the biofilm inhibition and
dispersion effect. Dendrimer FD2 was additionally tested for
cytotoxicity against a human cell line using an LDH cytotoxicity
assay and did not show any significant increase in LDH release
up to concentrations of 0.1 mM over the untreated controls (Ta-
ble S1 and Figure S6). The fact that potent lectin recognition was
obtained with dendrimers bearing cationic but also anionic and
neutral amino acids suggests that fine-tuning of the structure
should be possible by amino acid modification.
SIGNIFICANCE
Thewidespread occurrence and significant impact ofP. aer-
uginosa biofilms in a variety of clinical settings offers prom-
ising opportunities to exploit the actions of anti-lectin
agents. Beyond cystic fibrosis,P. aeruginosa is an important
respiratory pathogen in pneumonia and chronic obstructive
airways disease. It is also a major colonizer of chronic
wounds such as burns and diabetic foot ulcers. Beyond
the clinical setting, P. aeruginosa biofilm formation leads
to contamination of industrial and commercial waste pipes.
The economic implications of these effects are sizeable in
terms of costs to patients and their caregivers, health care
providers, industrial and commercial sectors, and in general
the global economy.
Inhibition and dispersion of biofilms provides an attractive
antibacterial strategy against P. aeruginosa, which can be
resistant to multiple antibiotic agents. Interfering with bio-
films is expected to escape resistance because the effect
is not lethal to the bacterium and would only restore sensi-
tivity to antibiotics or allow clearance by the host immune
system. In the present experiments, we have shown that
interference with LecB can lead to complete inhibition and
dispersion of biofilms, which clearly marks this lectin as
a valuable target for developing biofilm inhibitors. The glyco-
peptide dendrimer ligands are readily amenable to structural
modifications and large-scale synthesis by standard SPPS
for further development as selective biofilm-dispersion
agents. Such agents would have great clinical significance
given the difficulties of treating P. aeruginosa biofilm-cen-
tered human infections.
EXPERIMENTAL PROCEDURES
Library Synthesis
The peptide-dendrimer library was prepared from a 500 mg resin batch of
NovaSyn TG (0.30 mmol/g) divided equally in five reactors. In each of the
reactors, the resin was acylated with one of the five amino acids (3 Eq) in
the presence of BOP (3 Eq) and DIEA (5 Eq). Amino acids were acylated
for 1.5 hr. After each coupling, the five resin batches were then mixed to-
gether and split into five parts, equally introduced in the five reactors. These
split-and-mix steps were repeated after each amino acid coupling. After
each coupling the resin was successively washed with NMP, MeOH, and
CH2Cl2 (three times with each solvent), then checked for free amino groups
with the TNBS test. Proline coupling was checked with the chloranil test. If
the test indicated the presence of free amino groups, the coupling was re-
peated. The Fmoc-protecting groups were removed with a solution of 20%1254 Chemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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At the end of the synthesis, the Fmoc-protected resin was dried and stored
at 4C.
Just before screening, the Fmoc-protecting groups were removed and the
library was capped with a C-fucoside residue 1 or 2 (5 Eq) in the presence of
DIEA (5 Eq) and HCTU (3 Eq) in NMP overnight. The side-chain-protecting
groups were removed with TFA/TIS/H2O (95:2.5:2.5) for 4 hr. Then the carbo-
hydrate was deacetylated with a solution of MeOH/NH3/H2O (v/v 8:1:1) for
24 hr, resulting in the glycopeptide dendrimer library on beads L1 or L2.
In the N-acetylated control library, Fmoc-protecting groups were removed
and the library was capped with Ac2O/CH2Cl2 1:1 for 30 min. The side-
chain-protecting groups were removed with TFA/TIS/H2O (95:2.5:2.5) for
4 hr to give a library with acetylated N-termini and free 3-lysine side chains.
Expression and Purification of LecB
The lecB gene ofP. aeruginosa on plasmid pEC2was expressed in Escherichia
coli BL21(DE3) (Loris et al., 2003; Tielker et al., 2005 ; Tielker et al., 2006). Bac-
terial cells were grown at 37C in Luria-Bertani medium containing 0.4% (w/v)
glucose to an absorbance at 580 nm of 0.6 and then induced with 0.5 mM
isopropyl-b-D-thiogalactoside. After an additional 16 hr of growth, cells were
harvested by centrifugation at 8000 g for 10 min and suspended in 20 ml
100 mM Tris-HCl buffer (pH 8.0).
LecB was purified by affinity chromatography after lysis of the bacterial cells
by sonication (Sonopuls HD60, Bandelin, Berlin, 3 3 4 min at 30 W). The cell
lysate was centrifuged at 10,000 g for 30 min, and the supernatant was loaded
onto amannose agarose column (Sigma, volume 20ml) previously equilibrated
by washing with 100 ml 100 mM Tris-HCl (pH 8.0). The column was washed
with 200 ml saline to remove unspecifically bound proteins. LecB was eluted
with 50 ml 20 mM D-mannose in 100 mM Tris-HCl buffer (pH 8.0). LecB-con-
taining fractions were identified by SDS-PAGE and subsequent gel staining
with Coomassie-Brilliant Blue R-250 and concentrated by ultrafiltration using
Vivaspin 20 devices (Virafines, 5 kDa cut-off) and the buffer subsequently re-
placed by ultrapurewater. The LecB yield usually was 60mg per liter of culture,
and the pure lectin protein was stored in aliquots at a concentration of 1 mg/ml
at 20C.
Labeling of LecB with Rhodamine B isothiocyanate
The LecB lectin (0.5 mg in 400 ml PBS buffer, pH 8.3) was labeled with Rhoda-
mine B isothiocyanate (0.18 mg in 400 ml of same buffer) giving a lectin/dye =
1:4 (per lysine), for 21 hr at room temperature. Purification was performed
using a HiTrap desalting column (eluent PBS buffer, pH 7.2). The fractions
were checked using SDS-PAGE 20% standard and labeled lectin was ob-
served at a wavelength of 473 nm.
On-Bead Immunosorbent Lectin Binding Assay
Fifty milligrams of the glycodendrimer library on TG resin was washed three
times with 1 ml PBST buffer (2 mM Na2HPO4, 10 mM NaH2PO4, 150 mM
NaCl, 0.05% Tween-20, pH 6.8) and then suspended in 2 ml PBST buffer con-
taining 3% bovine serum albumin (BSA). After having been shaken for 30 min,
the beads were washed three times with 1 ml PBST buffer containing 1% BSA
and subsequently incubated for 1 hr at room temperaturewith 1ml of a solution
of Rhodamine-B-labeled LecB (6 mg/ml). After removal of lectin solution, the
beads were incubated with 0.45 M L(-)-fucose in PBST buffer for another
1 hr. The beads were washed three times with 1 ml PBST buffer and twice
with 1 ml water and monitored under a fluorescence microscope (Axiovert
35). Fluorescent beads were manually selected and washed with 90% TFA
aqueous solution (10 3 1 ml), water (ten times), MeOH (two times), CH2Cl2
(five times), MeOH (two times), and water (five times) in order to remove bound
lectin. The screening was repeated with 3 M L(-)-fucose solution and without
fucose competition. Negative control was done with acetylated library and
no lectin binding was observed in this case.
Sequence Determination
Single dendrimer-containing resin beads were hydrolyzed with aqueous HCl
(6M) at 110C for 22 hr. The amino acids were derivatized with phenylisothio-
cyanate and the phenylthiocarbamoyl derivatives were analyzed on a reverse-
phase C18 Novapack column.
Procedure for Dendrimer Synthesis
Peptide syntheses were performed manually in a glass reactor or plastic syrin-
ges (5 or 10 ml). The resin NovaSyn TGR (loading: 0.18–0.29 mmol/g) was
acylated with each amino acid or diamino acid (3 Eq) in the presence of BOP
or PyBOP (3 Eq) and DIEA (5 Eq) for 1.5 hr (3 hr after the first generation). After
each coupling, the resin was successively washed with NMP, MeOH, and
CH2Cl2 (three times with each solvent), then checked for free amino groups
with the TNBS test. If the TNBS test indicated the presence of free amino
groups, the couplingwas repeated. After each coupling, the potential remaining
free amino groups were capped with acetic anhydride/CH2Cl2 for 10 min. The
Fmoc-protecting groups were removed with a solution of 20% piperidine in
DMF (23 10min) and the solvent was removed by filtration. In the end of the se-
quence the resinwas cappedwithC-fucosyl acid 1 (5 Eq) in thepresence of DIC
(5 Eq) and HOBt (5 Eq) or DIEA (5 Eq) and HCTU (3 Eq) in NMP overnight. The
carbohydrate was deprotected with a solution of MeOH/NH3/H2O (v/v 8:1:1)
for 24 hr. The resin was dried and the cleavage was carried out with TFA/TIS/
H2O (95:2.5:2.5) for 4 hr. The peptide was precipitated with methyl tert-butyl
ether thendissolved in awater/acetonitrilemixture. All dendrimerswerepurified
bypreparativeHPLCwithdetectionat l=214nm.Eluent Acontainedwater and
TFA (0.1%); eluent B contained acetonitrile, water, and TFA (3/2/0.1%).
Enzyme-Linked Lectin Assays
Enzyme-linked lectin essays were conducted using 96-well microtiter plates
(Nunc Maxisorb) coated with LecB lectin (5 mg/ml) diluted in carbonate buffer
(pH 9.6, 100 ml) for 1 hr at 37C. After removal of lectin, the wells were blocked
with 100 ml per well of 3% (w/v) BSA in PBS at 37C for 1 hr. BSA solution was
removed and each inhibitor was added in serial 2-fold dilutions (54 ml/well) in
PBS to lectin-coated microplates and incubated at 37C for 1 hr. Then 54 ml
of biotinylated polymeric fucose (Lectinity Holding, Inc.) at 5 mg/ml was added
to the above solutions of inhibitors and the plates were incubated for another
hour at 37C. After washing (three timeswith 150 ml/well) with T-PBS (PBS con-
taining 0.05% Tween), 100 ml streptavidin-peroxidase conjugate (dilution
1:5000 in PBS) was added and left for 1 hr at 37C. Thewells were thenwashed
three times with 150 ml/well with T-PBS and once with water, and 50 ml/well
of 2,20-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
(ABTS) (1 mg per 4 ml) in citrate phosphate buffer (0.2 M, pH 4.0 with
0.015% [v/v] H2O2) was added. The reaction was stopped after 20 min by add-
ing 50 ml/well 1 M H2SO4. Absorbance was read at 415 nm using a microtiter
plate reader (spectra MAX 250). Every experiment was made in triplicate.
Determination of IC50 Values
The logarithm of the concentration of the dendrimer was plotted versus the
percentage of inhibition. The sigmoidal curve was fitted and the concentration
at 50% of inhibition was determined. The percent of inhibition was calculated
as follows: Inhibition (%) = [(Amax-A)/Amax] 3 100. Amax corresponds to
the mean value of the higher absorption limit reached in the dilution series
and not to an external reference. Percent inhibition was plotted versus log C
(inhibitor).
Steel Coupon Assay
Biofilms were grown on stainless steel coupons (grade 316L) under conditions
similar to those described previously (Dhir and Dodd, 1995). Sterile steel cou-
pons were placed at the edges of Petri dishes with 10 ml 0.05% (v/v) nutrient
broth no. 2 (Oxoid) containing the appropriate concentration of the test com-
pound. Inocula of P. aeruginosa strains PAO1, PAO1DlecA, PAO1DlecB, and
PAO1DlecADlecB were prepared from 5 ml overnight cultures grown in LB
broth. The optical density (600 nm) was corrected to 1 and aliquots of 100 ml
were used to inoculate the medium contained within the Petri dishes. The Petri
dishes were incubated at 37C on a rotary shaker (60 rpm) for 24 hr. An
additional 100 ml LB broth was added and the Petri dishes were incubated
for a further 24 hr. The test was performed in triplicate for each strain.
Acridine Orange Staining of Stainless Steel Coupon Biofilms
The inoculatedmediumwas removed from the Petri dish with a transfer pipette
without disturbing the steel coupons. Fifteen milliliters sterile PBS was then
added and the dish agitated gently for 5 min to rinse the coupons. The PBS
was removed and this rinse step was repeated. Following this, the coupons
were air-dried and then heat-fixed by passing them through a Bunsen flameChemistry & Biology 15, 1249–1257, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1255
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200 ml 0.1% (w/v) acridine orange to the upper surface of each coupon for
2.5 min. To remove unbound acridine orange, 20 ml sterile PBS was then
added to the Petri dish and the dish gently agitated as before for 5 min. The
PBS was removed and this wash step was repeated two more times. The
coupons were then air-dried and fixed with tape along their edges to a glass
microscope slide.
Visualization of Biofilms
The coupons were examined for bacterial attachment with an inverted fluores-
cent microscope (Nikon Eclipse TE200) using the310 objective lens and green
filter. Ten images were collected per coupon using a JVC KY-F58 video cam-
era. Sampling was conducted at random from each coupon, avoiding areas at
the edges. With the ‘‘red’’ and ‘‘low’’ options set to the maximum level of 255,
the area fraction for each image was calculated using the Lucia G/Comet soft-
ware (Nikon UK) with a threshold set at between 175 and 185.
Capturing of Confocal Images
Coupons were placed in the universal slide holder of an inverted Zeiss Axio-
vert100M microscope and confocal images and Z-stacks were captured
with a Zeiss LSM510uv META Combi confocal system. The objective used
was a Zeiss Plan-NeoFluar 40x/1.3 oil immersion and the acridine orange
was excited with an argon laser at 488nm and emission collected with a
LP560 filter.
Tecan Scan (Growth Curve)
An overnight culture of P. aeruginosa strain PAO1, grown in LB, was standard-
ized to an OD600 of 0.1 and aliquots were inoculated in test wells of a 96-well
plate.Theappropriate volumeof the testcompoundswasadded togive thefinal
test concentrations in a 300 ml volume. Growth (optical density at 600 nm) was
measured over 24 hr at 37C in Tecan, a combined photometer/luminometer.
Dispersion Test
Biofilms were grown on stainless steel coupons (grade 316L) under conditions
similar to those described elsewhere (Dhir and Dodd, 1995). Sterile steel cou-
pons were placed at the edges of Petri dishes with 10 ml 0.05% (v/v) nutrient
broth. Inocula of P. aeruginosa, strain PAO1were prepared from 5ml overnight
cultures grown in LBbroth. The optical density (600 nm) was corrected to 1 and
aliquots of 100 ml were used to inoculate the medium contained within the Petri
dishes. The Petri dishes were incubated at 37C on a rotary shaker (60 rpm) for
24 hr. An additional 100 ml LB broth was added and the Petri dishes were
incubated for a further 24 hr. The inoculated medium was removed from the
Petri dish with a transfer pipette without disturbing the steel coupons and
the coupons were rinsed with 10 ml 0.05% nutrient broth. Then, 10 ml
0.05% (v/v) nutrient broth containing the appropriate concentration of the
test compound was added to each Petri dish. To the control dish, 0.05% nu-
trient broth alone was added. The dishes were incubated at 37C on a rotary
shaker (60 rpm) for 2 hr. Themedia was collected, vortexed, and serially diluted
to a final dilution of 1:10,000. Aliquots of 100 ml were spread onto LB agar
plates in triplicate and incubated at 37C overnight. The resulting colonies
were counted and a calculation of the viable bacterial count made.
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